Hong L. Lung

Sar, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Development of a Modular Ribonucleoprotein Complex as a General Strategy to Deliver RNAi Therapeutics.

Development of a Modular Ribonucleoprotein Complex as a General Strategy to Deliver RNAi Therapeutics.

Journal: Advanced healthcare materials
Published: July 02, 2025

THY1 (CD90) Maintains the Adherens Junctions in Nasopharyngeal Carcinoma via Inhibition of SRC Activation.

THY1 (CD90) Maintains the Adherens Junctions in Nasopharyngeal Carcinoma via Inhibition of SRC Activation.

Journal: Cancers
Published: February 25, 2023

EBV latent membrane protein 1 augments γδ T cell cytotoxicity against nasopharyngeal carcinoma by induction of butyrophilin molecules.

EBV latent membrane protein 1 augments γδ T cell cytotoxicity against nasopharyngeal carcinoma by induction of butyrophilin molecules.

Journal: Theranostics
Published: August 26, 2022

The CBP/β-Catenin Antagonist, ICG-001, Inhibits Tumor Metastasis via Blocking of the miR-134/ITGB1 Axis-Mediated Cell Adhesion in Nasopharyngeal Carcinoma.

The CBP/β-Catenin Antagonist, ICG-001, Inhibits Tumor Metastasis via Blocking of the miR-134/ITGB1 Axis-Mediated Cell Adhesion in Nasopharyngeal Carcinoma.

Journal: Cancers
Published: June 13, 2022

Lanthanide-Based Peptide-Directed Visible/Near-Infrared Imaging and Inhibition of LMP1.

Lanthanide-Based Peptide-Directed Visible/Near-Infrared Imaging and Inhibition of LMP1.

Journal: JACS Au
Published: April 28, 2021

The Role of EBV-Encoded LMP1 in the NPC Tumor Microenvironment: From Function to Therapy.

The Role of EBV-Encoded LMP1 in the NPC Tumor Microenvironment: From Function to Therapy.

Journal: Frontiers in oncology
Published: December 10, 2020

Dual-Targeting Peptide-Guided Approach for Precision Delivery and Cancer Monitoring by Using a Safe Upconversion Nanoplatform.

Dual-Targeting Peptide-Guided Approach for Precision Delivery and Cancer Monitoring by Using a Safe Upconversion Nanoplatform.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 31, 2020

The Therapeutic Potential of Targeting BARF1 in EBV-Associated Malignancies.

The Therapeutic Potential of Targeting BARF1 in EBV-Associated Malignancies.

Journal: Cancers
Published: June 28, 2020

Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma.

Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma.

Journal: Frontiers in oncology
Published: January 03, 2020

Reactivation of Epstein-Barr virus by a dual-responsive fluorescent EBNA1-targeting agent with Zn2+-chelating function.

Reactivation of Epstein-Barr virus by a dual-responsive fluorescent EBNA1-targeting agent with Zn2+-chelating function.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 12, 2019

Serum amyloid A1 polymorphisms as risk factors in oesophageal squamous cell carcinoma.

Serum amyloid A1 polymorphisms as risk factors in oesophageal squamous cell carcinoma.

Journal: Hong Kong medical journal = Xianggang yi xue za zhi
Published: November 26, 2019

Nuclear DLC1 exerts oncogenic function through association with FOXK1 for cooperative activation of MMP9 expression in melanoma.

Nuclear DLC1 exerts oncogenic function through association with FOXK1 for cooperative activation of MMP9 expression in melanoma.

Journal: Oncogene
Published: October 22, 2019
Showing 1-12 of 31

Last Updated: 09/26/2026